GlassScriptPhysician profile
Laura A Sproat
NPI 1558570374
$1,565.73
in general payments reported to CMS, 2019-2025
27 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $236 · 2021: $61.18 · 2022: $170 · 2023: $125 · 2024: $298 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $289.05 | 2019-2025 | Veozah, Myrbetriq |
| Lupin INC. | $171.90 | 2019-2020 | |
| Abbvie INC. | $144.78 | 2019-2022 | |
| Gynesonics, INC. | $126.06 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $122.69 | 2019-2022 | |
| Hologic Sales and Service, LLC | $102.49 | 2021-2024 | Thinprep 2000 Processor, Aptima |
| Exeltis, USA INC. | $101.27 | 2019-2024 | Slynd |
| Daiichi Sankyo INC. | $68.32 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $59.11 | 2019-2020 | |
| Pfizer INC. | $49.12 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $43.57 | 2019-2020 | |
| Duchesnay USA Incorporated | $36.89 | 2019 | |
| Covidien LP | $29.53 | 2019 | |
| Si-Bone, INC. | $20.97 | 2022 | |
| Almatica Pharma LLC | $20.04 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $17.87 | 2023 | Gemtesa |
| Organon LLC | $17.64 | 2022 | |
| Scynexis, INC. | $17.01 | 2022 | |
| Coopersurgical, INC. | $16.96 | 2019 | |
| Allergan, INC. | $16.61 | 2019 | |
| Becton, Dickinson and Company | $14.48 | 2022 | |
| Avion Pharmaceuticals | $14.47 | 2020 | |
| Lilly USA, LLC | $14.08 | 2020 | |
| Sage Therapeutics, LLC | $13.92 | 2024 | |
| Coloplast Corp | $13.73 | 2021 | |
| Medicem INC. | $11.71 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Sproat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.